Developing genetic treatments for patients with very rare mutations
Annemieke Aartsma-Rus published an article about DCRT in Nature Medicine! In this article Annemieke tells about "N of 1" therapies, RNA therapies that are only suitable for one patient. DCRT is developing individualized ASOs for
patients with genetic brain or eye disorders and Annemieke summarizes the challenges that we face in these studies.
To read the whole article, go to Nature Medicine Worldview of 24th of May 2021.
published on May 25, 2021
Jan Veldink (UMCU) and Peter van den Akker (UMCG) will become DCRT partners in 2026.
DCRT researchers to attend the N1C annual meeting and the OTS in Budapest in October
DCRT presentations at the 4th DATS in Groningen
Bachelor student Noortje Groenendijk joins DCRT for an internship
Keynotes, invited speakers and sponsors at DATS 2025 in Groningen
Master student Tracy Wüsthoff joins the DCRT for an internship
Come and join the DCRT at the Dutch Antisense Therapeutics Symposium in Groningen!
Master student Okke Faber joins the DCRT
DCRT's Ype Elgersma will be interviewed on television about his work on epilepsy
Happy Christmas holidays from all of us at DCRT!